TCL Archive FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says. January 14, 2005
TCL Archive CCRAC Calls for New Comp Center, Community Hospital Core Grants For Control Development August 24, 1979
TCL Archive In Brief: Control Grant Review committee Out Of Grants Division Provisional Training Announcement Due October 10, 1975
TCL Archive Medicare increases payments for oncology infusion and begins a one-year demonstration project that pays oncologists to assess the side effects of chemotherapy. November 5, 2004
TCL Archive New Version Of NCI Proposed IP Agreement Quiets Some Unease At Cooperative Groups; Advisors Urge “No Paralysis” While Awaiting New Language November 13, 2009
